INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 02, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 28,290 | $310.14 | 20,859,531 |
| Nov 26, 2012 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 28,507 | $175.12 | 178,826 |
| Oct 23, 2014 |
SVP Administration & Asst Secr
Trans History: 645
|
SVP Administration & Asst Secr | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 28,523 | $391.93 | 89,890 |
| Aug 25, 2017 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 28,586 | $479.93 | 23,840,429 |
| Oct 17, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 427
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Open market or private sale of non-derivative or derivative security | 28,656 | $18.00 | 63,009 |
| Jul 11, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 28,662 | $314.19 | 21,858,104 |
| Dec 14, 2010 |
SVP Clinical Development
Trans History: 208
|
SVP Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 28,736 | -- | 28,736 |
| Feb 13, 2012 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 28,869 | $113.35 | 88,745 |
| Dec 16, 2015 |
SVP Finance & CFO
Trans History: 465
|
SVP Finance & CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 28,900 | -- | 28,900 |
| Dec 16, 2015 |
SVP General Counsel and Secret
Trans History: 181
|
SVP General Counsel and Secret | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 28,900 | -- | 28,900 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.